Back to ELVN
Candriam S.C.A. ELVN Position History
Enliven Therapeutics, Inc. • Healthcare
Quarters held
6
Latest value
$38.9M
Q3 2026
Peak value
$45.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $12.5M |
| Q4 2025 | $7M |
| Q4 2025 | $7M |
| Q1 2026 | $23.3M |
| Q2 2026 | $45.9M |
| Q3 2026 | $38.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $38.9M | 846.5K | — | — |
| Q2 2026 | $45.9M | 905.7K | — | — |
| Q1 2026 | $23.3M | 594.1K | — | — |
| Q4 2025 | $7M | 453.0K | — | — |
| Q4 2025 | $7M | 453.0K | — | — |
| Q3 2025 | $12.5M | 609.4K | — | — |